Takafumi Ide

Takafumi Ide

Bristol-Myers Squibb Co. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5466338
-
person_outline Takafumi Ide's MOST POPULAR ARTICLES
1-) Quantitative Population Pharmacokinetic Analysis of Pravastatin Using an Enterohepatic Circulation Model Combined With Pharmacogenomic Information on SLCO1B1 and …T Ide, T Sasaki, K Maeda, S Higuchi, Y Sugiyama, I IeiriThe Journal of Clinical Pharmacology 49 (11), 1309-1317, 2009352009
2-) Population pharmacokinetic and exposure–response analyses of elotuzumab plus pomalidomide and dexamethasone for relapsed and refractory multiple myelomaT Ide, M Osawa, K Sanghavi, HE VezinaCancer Chemotherapy and Pharmacology 89 (1), 129-140, 202232022
3-) Model‐Based Determination of Elotuzumab Pharmacokinetics in Japanese Patients With Multiple Myeloma Incorporating Time‐Varying M ProteinT Ide, A Roy, Y Imai, HE VezinaThe Journal of Clinical Pharmacology 61 (1), 64-73, 202122021
4-) Safety and Pharmacokinetics of Multiple-Dose BMS-986036 in Healthy Japanese and NonJapanese AdultsG Tirucherai, T Ide, D Shevell, J Mora, ED CharlesHepatology 68, 756A-757A, 201822018
5-) LP-182 Pharmacokinetics, selectivity profile, and exposure-response relationship for efficacy and safety in a phase 2 study of deucravacitinib, an oral, selective, allosteric …T Ide, M Chiney, HYT Bach, V Goti, B Murthy, C Hobar, Q Zhao, U ArasLupus Science & Medicine 10 (Suppl 1), 20232023